View in EDS HTML Full Text PDF Full Text

Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk.

Saved in:
Bibliographic Details
Title: Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk.
Authors: Sarkar S; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC, USA. ss4235@georgetown.edu., Schechter C; Department of Family and Social Medicine, Albert Einstein College of Medicine, New York City, NY, USA., Kurian AW; Department of Medicine (Oncology) and Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA., Caswell-Jin JL; Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA., Jayasekera J; Health Equity and Decision Sciences Laboratory, National Institute on Minority Health and Health Disparities, National Institutes of Health, Rockville, MD, USA., Mandelblatt JS; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC, USA.; Georgetown Lombardi Institute for Cancer and Aging REsearch (I-CARE), Lombardi Comprehensive Cancer Center, Washington, DC, USA.
Source: NPJ breast cancer [NPJ Breast Cancer] 2025 Mar 26; Vol. 11 (1), pp. 30. Date of Electronic Publication: 2025 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40140385
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sarkar+S%22">Sarkar S</searchLink>; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC, USA. ss4235@georgetown.edu.<br /><searchLink fieldCode="AU" term="%22Schechter+C%22">Schechter C</searchLink>; Department of Family and Social Medicine, Albert Einstein College of Medicine, New York City, NY, USA.<br /><searchLink fieldCode="AU" term="%22Kurian+AW%22">Kurian AW</searchLink>; Department of Medicine (Oncology) and Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Caswell-Jin+JL%22">Caswell-Jin JL</searchLink>; Department of Medicine (Oncology), Stanford University School of Medicine, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Jayasekera+J%22">Jayasekera J</searchLink>; Health Equity and Decision Sciences Laboratory, National Institute on Minority Health and Health Disparities, National Institutes of Health, Rockville, MD, USA.<br /><searchLink fieldCode="AU" term="%22Mandelblatt+JS%22">Mandelblatt JS</searchLink>; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC, USA.; Georgetown Lombardi Institute for Cancer and Aging REsearch (I-CARE), Lombardi Comprehensive Cancer Center, Washington, DC, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2025 Mar 26; Vol. 11 (1), pp. 30. <i>Date of Electronic Publication: </i>2025 Mar 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40140385
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-025-00746-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 30
    Titles:
      – TitleFull: Impact of endocrine therapy regimens for early-stage ER+/HER2-breast cancer on contralateral breast cancer risk.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sarkar S
      – PersonEntity:
          Name:
            NameFull: Schechter C
      – PersonEntity:
          Name:
            NameFull: Kurian AW
      – PersonEntity:
          Name:
            NameFull: Caswell-Jin JL
      – PersonEntity:
          Name:
            NameFull: Jayasekera J
      – PersonEntity:
          Name:
            NameFull: Mandelblatt JS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 03
              Text: 2025 Mar 26
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1